Cargando…
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: A novel strategy for human BRAF-driven colorectal carcinoma
The HSP90 chaperone TRAP1 is translational regulator of BRAF synthesis/ubiquitination, since BRAF down-regulation, ERK signaling inhibition and delay of cell cycle progression occur upon TRAP1 silencing/inhibition. Since TRAP1 is upregulated in human colorectal carcinomas (CRCs) and involved in prot...
Autores principales: | Condelli, Valentina, Maddalena, Francesca, Sisinni, Lorenza, Lettini, Giacomo, Matassa, Danilo Swann, Piscazzi, Annamaria, Palladino, Giuseppe, Amoroso, Maria Rosaria, Esposito, Franca, Landriscina, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673164/ https://www.ncbi.nlm.nih.gov/pubmed/26084290 |
Ejemplares similares
-
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
por: Notarangelo, Tiziana, et al.
Publicado: (2017) -
TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas
por: Maddalena, Francesca, et al.
Publicado: (2020) -
TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial–mesenchymal transition
por: Amoroso, Maria R, et al.
Publicado: (2016) -
TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation
por: Bruno, Giuseppina, et al.
Publicado: (2022) -
HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy
por: Condelli, Valentina, et al.
Publicado: (2019)